細胞番号 : 細胞名
RCB4569 : TEC3-10
update : 2024/11/11
|
細胞特性(Comment:英) | Culture of Thymic Epithelial Cell Lines., Protocol (pdf:120KB) |
細胞特性(日) | |
細胞特性(寄託者記述:英) | A mouse thymic medullary epithelial cell line. It has the ability to present soluble antigen to its antigen specific helper T cells. This cell line is available to analyze the functions of cortical epithelial cells and medullary epithelial cells that control the differentiation and selection of intrathymic T cells. It is also useful for attempts such as thymus reconstruction using these cell lines, aiming at such functional recovery. |
細胞特性(寄託者記述:日) | マウス胸腺髄質部由来上皮細胞株。可溶性抗原をその抗原特異的ヘルパーT細胞に提示する能力を有する。胸腺内T細胞の分化と選択を制御する皮質上皮細胞と髄質上皮細胞の機能の解析、そのような機能回復を目指し、これら細胞株を用いた胸腺再構築の試み等に有用。 |
使用条件(英) | In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Cell Immunol. 1991;132:377-390., J Exp Med. 1992;175:1601-1605. and Methods Mol Biol. 2007;380:107-123.) designated by the DEPOSITOR is required. |
使用条件(日) | 利用者は、研究成果の公表にあたって寄託者の指定する文献 (Cell Immunol. 1991;132:377-390., J Exp Med. 1992;175:1601-1605. and Methods Mol Biol. 2007;380:107-123.) を引用すること。 |
備考(英) | |
備考(日) | |
提供申込書類(英) |
Order Form(C-0005.pdf)
 
MTA(C-0007.pdf)
 
MTA(C-0007p.pdf)
 
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
提供申込書類(日) |
依頼書C-0001.pdf
 
同意書(非営利学術目的)C-0003.pdf
 
同意書(営利目的)C-0003p.pdf
 
|
提供同意書は、使用機関の種類や目的に応じて、非営利学術目的 (C-XXXX) と営利目的 (C-XXXXp) の2種類があります。該当する提供同意書をご使用ください(詳細)。特許等の取得及び商業利用等は事前に必ず cellbank.brc@riken.jp までご連絡ください。
|
提供手数料 |
手数料とお支払いについてはこちらをご覧ください。 |
細胞基本情報
|
|
寄託者 |
KASAI, Michiyuki
|
樹立者 |
KASAI, Michiyuki
|
寄託日 |
2014
|
元の細胞 |
medullary TEC line (mTEC line)
|
クローニング(寄託者) |
Yes
|
動物種 |
_mouse
< Mammals
|
動物系統名 |
C57BL/6
|
性別 |
Unknown
|
齢 |
15 weeks
|
採取組織 |
thymus
|
細胞分類 |
normal
|
遺伝子改変 |
non-recombinant
|
|
細胞寿命 |
infinite
|
細胞形態 |
epithelial-like
|
Cellosaurus(Expasy) |
CVCL_A8W9
|
細胞培養・検査情報
| |
寄託時情報 |
ロット情報 |
培地・試薬情報 |
培地・試薬一覧はこちらをご覧ください。 |
|
培養形態 |
Adherent cells
|
Adherent cells
|
培地 |
SMEM (gibco 11380) + 10%FBS + 1μg/mL Hydrocortisone + 60μM 2-ME
|
MEM (suspension, 2mM L-Glutamine) + 10%FBS + 1μg/mL Hydrocortisone + 60μM 2-ME
|
抗生物質 |
25mg/500mL gentamicin
|
Free
|
|
継代方法 |
|
0.25% Trypsin + (0.02% EDTA or 0.04% EDTA)
|
|
播種細胞数 |
1×10 5 cells / 60mm dish
|
|
継代密度 |
|
1 : 4-8 split
|
継代・培地交換頻度 |
Subculture : once/3-4 days
|
Subculture : 2 times/week
|
培養最適温度 |
37
℃
|
37
℃
|
二酸化炭素濃度 |
5
%
|
5
%
|
フィーダー細胞 |
Swiss 3T3
|
3T3 Swiss Albino
|
フィーダー細胞 番号 |
|
RCB1642
|
フィーダー細胞の処理方法 |
X-rays
|
X-rays 5000R
|
凍結培地 |
Medium + 10% DMSO
|
Medium + 10% DMSO
|
凍結方法 |
|
Slow freezing
|
マイコプラズマ/アコレプラズマ |
|
(-)
|
動物種PCR |
|
OK
|
マウス系統検査 |
|
OK
|
画像情報 |
寄託時情報 | ロット情報 |
|
|
文献情報 |
Reference(英) |
7件
|
Reference(日) |
0件
|
利用者成果(英) |
0件
|
利用者成果(日) |
0件
|
Reference(英) |
4565
Kasai M, Tanida I, Ueno T, Kominami E, Seki S, Ikeda T, Mizuochi T.
Autophagic compartments gain access to the MHC class II compartments in thymic epithelium.
J Immunol
2009
183:7278-785
PubMed ID: 19915056
DOI: 10.4049/jimmunol.0804087
|
4564
Kasai M, Mizuochi T.
Derivation, Culture, and Characterization of Thymic Epithelial Cell Lines
Methods Mol Biol
2007
380:107-123
PubMed ID: 17876090
DOI: 10.1007/978-1-59745-395-0_7
|
4563
Kasai M, Kropshofer H, Vogt AB, Kominami E, Mizuochi T.
CLIP-derived self peptides bound to MHC class II molecules of medullary thymic epithelial cells differ from those of cortical thymic epithelial cells in their diversity, length, and C-terminal processing.
Eur J Immunol
2000
30:3542-3551
PubMed ID: 11169395
DOI: 10.1002/1521-4141(200012)30:12<3542::AID-IMMU3542>3.0.CO;2-N
|
4562
Kasai M, Kominami E, Mizuochi T.
The antigen presentation pathway in medullary thymic epithelial cells, but not that in cortical thymic epithelial cells, conforms to the endocytic pathway.
Eur J Immuno
1998
28:1867-1876
PubMed ID: 9645368
DOI: 10.1002/(SICI)1521-4141(199806)28:06<1867::AID-IMMU1867>3.0.CO;2-K
|
4561
Kasai M, Shirasawa T, Kitamura M, Ishido K, Kominami E, Hirokawa K.
Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody.
Cell Immunol
1993
150:124-136
PubMed ID: 8343964
DOI: 10.1006/cimm.1993.1184
|
4560
Mizuochi T, Kasai M, Kokuho T, Kakiuchi T, Hirokawa K.
Medullary but not cortical thymic epithelial cells present soluble antigens to helper T cells.
J Exp Med.
1992
175:1601-1605
PubMed ID: 1534114
DOI: 10.1084/jem.175.6.1601
|
4559
Kasai M, Hirokawa K.
A novel cofactor produced by a thymic epithelial cell line: promotion of proliferation of immature thymic lymphocytes by the presence of interleukin-1 and various mitogens.
Cell Immunol
1991
132:377-390
PubMed ID: 1988159
DOI: 10.1016/0008-8749(91)90035-a
|